ADAM33 and asthma: Initially identified as an asthma susceptibility gene [76,77,78,79], ADAM33 is expressed in vascular smooth muscle cells and tissues including the lungs, where it contributes to airway remodeling, angiogenesis, and chronic inflammation, for instance, in cases of allergic rhinitis [80,81].